Search Results - Hanrui Zheng
- Showing 1 - 6 results of 6
-
1
Cost-Effectiveness Analysis of Pembrolizumab in Patients With Advanced Esophageal Cancer Based on the KEYNOTE-181 Study by Mei Zhan, Mei Zhan, Ting Xu, Hanrui Zheng, Hanrui Zheng, Zhiyao He
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Cost-effectiveness analysis of toripalimab plus chemotherapy as the first-line treatment in patients with advanced non-small cell lung cancer (NSCLC) without EGFR or ALK driver mut... by Kexun Zhou, Pei Shu, Hanrui Zheng, Qiu Li
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma by Qian Xie, Hanrui Zheng, Ye Chen, Xingchen Peng
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma by Qian Xie, Hanrui Zheng, Ye Chen, Xingchen Peng
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Cost-effectiveness analysis of trastuzumab deruxtecan in patients with HER2-low advanced breast cancer based on DESTINY-Breast04 by Mei Zhan, Mei Zhan, Zijia Huang, Zijia Huang, Ting Xu, Ting Xu, Xinyi Xu, Hanrui Zheng, Hanrui Zheng, Fengbo Wu, Fengbo Wu
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials by Shiwen Yang, Ying Liu, Shengzhao Zhang, Fengbo Wu, Dan Liu, Qingfang Wu, Hanrui Zheng, Ping Fan, Na Su, Na Su
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book